Next Article in Journal
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study
Next Article in Special Issue
Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023
Previous Article in Journal
IgG Serum Antibodies to Shigella sonnei Lipopolysaccharide Are Inversely Associated with the Incidence of Culture-Proven S. sonnei Shigellosis in Israeli Children and Adolescents
Previous Article in Special Issue
Strategic Planning of a Joint SARS-CoV-2 and Influenza Vaccination Campaign in the UK
 
 
Article

Article Versions Notes

Vaccines 2024, 12(3), 240; https://doi.org/10.3390/vaccines12030240
Action Date Notes Link
article xml file uploaded 26 February 2024 04:37 CET Original file -
article xml uploaded. 26 February 2024 04:37 CET Update https://www.mdpi.com/2076-393X/12/3/240/xml
article pdf uploaded. 26 February 2024 04:37 CET Version of Record https://www.mdpi.com/2076-393X/12/3/240/pdf
article supplementary file uploaded. 26 February 2024 04:37 CET - https://www.mdpi.com/2076-393X/12/3/240#supplementary
article html file updated 26 February 2024 04:38 CET Original file https://www.mdpi.com/2076-393X/12/3/240/html
Back to TopTop